Across TCGA pan-cancer cohorts, OR52I2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR52I2’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OR52I2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52I2 is over-expressed in tumor.

PRAD and STAD are the cancer types where OR52I2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52I2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.103	<.001	2	view →
STAD	Male	All	+0.008	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR52I2 RNA expression & survival · all OR52I2 data types